| Literature DB >> 23113182 |
M Karami1, H Soori, A Bahadori Monfared.
Abstract
BACKGROUND: Knowledge of the magnitude of avoidable burden by risk factors is needed for health policy, priority setting, and preventing stroke. The aim of this study was to estimate the contribution of selected risk factors including hypertension, overweight, obesity, tobacco use, and physical inactivity to the attributable burden of stroke in Iran.Entities:
Keywords: Burden; Iran; Potential impact fraction; Risk factor; Stroke
Year: 2012 PMID: 23113182 PMCID: PMC3468982
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Risk factors, their exposure variables, theoretical and feasible -minimum-risk exposure distributions, disease outcomes for risk factors prevalence and magnitude of risk factors
| BMI≥ 25 | Stroke | Male | 1.35 | 39.04 [38.36,39.72] | 0 | 30 | 12.0 | 2.8 | |
| Female | 1.25 | 48.99 [48.34,49.63] | 0 | 40 | 10.9 | 2 | |||
| BMI≥ 30 | Stroke | Male | 1.5 | 10.10 [9.697,10.51] | 0 | 5 | 4.8 | 2.4 | |
| Female | 1.6 | 20.46 [19.96,20.98] | 0 | 12 | 10.9 | 4.5 | |||
| SBP ≥ 140 and/or DBP ≥ 90 mmHg and/or use of anti- hypertensive drugs | Stroke | Male | 5.43 | 16.07 [15.55,16.61] | 0 | 10 | 41.6 | 15.7 | |
| Female | 5.43 | 16.12 [15.72,16.52] | 0 | 10 | 41.7 | 15.8 | |||
| Percentage who currently smoke tobacco daily | Stroke | Male | 1.17 | 20.39 [19.84,20.95] | 0 | 10 | 3.4 | 1.71 | |
| Female | 1.17 | 1.02 [0.87,1.19] | 0 | [ | 0.2 | NA | |||
| Percentage with low levels of activity (defined as <600 MET-minutes/week) | Stroke | Male | 1.1 | 28.28 [27.41,29.17] | 0 | 15 | 2.8 | 1.3 | |
| Female | 1.1 | 49.91 [48.92,50.9] | 0 | 25 | 4.8 | 2.4 | |||
Reference 6
Reference 2
Because of the low prevalence of smoking in women (1.02), feasible minimum risk level was not defined.
Uncertainty intervals for PIFs based on estimated uncertainty ranges around point estimate of risk factors by Monte Carlo simulation procedure
| Males | 1.35 | 39.04 (28–50) | 12.0 (8.9–14.9) | 2.8 (0–6) | |
| Females | 1.25 | 48.99 (35–65) | 10.9 (8–14) | 2 (0- 5.4) | |
| Males | 1.5 | 10.10 (6–14) | 4.8 (2.9- 6.5) | 2.4 (0.5- 4.2) | |
| Females | 1.6 | 20.46 (15- 26) | 10.9 (8.3- 13.5) | 4.5 (1.7- 7.3) | |
| Males | 5.43 | 16.07 (12- 20) | 41.6 (34- 47) | 15.7 (5.8- 23.5) | |
| Females | 5.43 | 16.12 (12- 20) | 41.7 (34- 47) | 15.8 (5.8- 23.5) | |
| Males | 1.17 | 20.39 (15- 26) | 3.4 (2.5- 4.2) | 1.71 (0.8- 2.6) | |
| Females | 1.17 | 1.02 (0.7- 1.03) | 0.2 (0.1- 0.2) | - | |
| Males | 1.1 | 28.28 (20- 36) | 2.8 (2- 3.5) | 1.3 (0.5- 2) | |
| Females | 1.1 | 49.91 (35- 65) | 4.8 (3.4- 6.1) | 2.4 (1- 3.8) | |
Incorporating sources of uncertainty for the prevalence of corresponded risk factor